Evidence Based Management of Acute Heart Failure in the Era of COVID-19 Pandemic
Abstract This editorial is to highlight current issues of heart failure management during COVID-19 pandemic.
Main Author: | Lexin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-05-01
|
Series: | Intensive Care Research |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44231-022-00003-6 |
Similar Items
-
Safety and efficacy of ARNI (valsartan/sacubitril) vs ACEI (enalapril) in acute heart failure – A prospective observational study
by: Tahir Saleem Bhat, et al.
Published: (2022-05-01) -
Angiotensin-Converting Enzyme and Heart Failure
by: Sara Álvarez-Zaballos, et al.
Published: (2023-07-01) -
Angiotensin receptor blockers in heart failure after the ELITE II trial
by: Willenheimer Ronnie
Published: (2000-09-01) -
Efficacy of sacubitril/valsartan on improving clinical symptoms in patients with acute myocardial infarction complicated with heart failure: a retrospective study
by: Guiping Wang, et al.
Published: (2025-02-01) -
Do cardiologists at a university hospital adopt the guidelines for the treatment of heart failure?
by: Antonio Carlos Pereira Barretto, et al.
Published: (2001-07-01)